A complete understanding of herpesvirus morphogenesis requires studies of capsid assembly dynamics in living cells. Although fluorescent tags fused to the VP26 and pUL25 capsid proteins are available, neither of these components is present on the initial capsid assembly, the procapsid. To make procapsids accessible to live-cell imaging, we made a series of recombinant pseudorabies viruses that encoded green fluorescent protein (GFP) fused in frame to the internal capsid scaffold and maturation protease. One recombinant, a GFP-VP24 fusion, maintained wild-type propagation kinetics in vitro and approximated wild-type virulence in vivo. The fusion also proved to be well tolerated in herpes simplex virus. Viruses encoding GFP-VP24, along with a traditional capsid reporter fusion (pUL25/mCherry), demonstrated that GFP-VP24 was a reliable capsid marker and revealed that the protein remained capsid associated following entry into cells and upon nuclear docking. These dual-fluorescent viruses made possible the discrimination of procapsids during infection and monitoring of capsid shell maturation kinetics. The results demonstrate the feasibility of imaging herpesvirus procapsids and their morphogenesis in living cells and indicate that the encapsidation machinery does not substantially help coordinate capsid shell maturation.
T he herpesvirus structure consists of a double-stranded DNA (dsDNA) genome encased in an icosahedral capsid, which is surrounded by a tegument protein layer and a lipid envelope. Capsid assembly occurs in the nucleus in infected cells, beginning with a spherical procapsid precursor built around a protein scaffold that matures into a DNA-containing angularized capsid (reviewed in reference 1). Subsequently, mature capsids egress from the nucleus to the cytosol, where they acquire additional structural components to become infectious virions (reviewed in reference 2). Various aspects of the herpesvirus infectious cycle have been studied by live-cell microscopy using viruses encoding fluorescent-protein fusions. In particular, fusions with the capsid proteins VP26 and pUL25 are used to study capsid transport, intranuclear capsid dynamics, and nuclear egress (reviewed in reference 3). However, these proteins are not present on procapsid progenitors (4) (5) (6) (7) . While much has been learned by transmission electron microscopy and biochemical analysis of the initial stages of capsid assembly, procapsid dynamics and maturation have been inaccessible to direct observation in living cells.
Procapsids are assembled from several viral proteins: the major capsid protein (VP5), two triplex proteins (VP19C and VP23), the unique portal vertex protein (pUL6), and the large and small internal scaffolding proteins (pUL26 and pUL26.5, respectively). Once assembled, proteolytic activity embedded in the large scaffold protein triggers angularization of the capsid shell by severing the scaffold-capsid interaction (5, 8, 9) . Concurrent with capsid angularization, the pUL15/pUL28/pUL33 heterotrimeric terminase complex replaces the fragmented scaffold with the linear ds-DNA viral genome (10) . While the bulk of the scaffold is expelled from the capsid, the protease domain (VP24) is retained as a virion structural component (6, (11) (12) (13) (14) (15) . The angularized capsid surface acquires the VP26 and pUL25 accessory capsid proteins, while the terminase is lost (4) (5) (6) (7) . Three angularized capsid types accumulate in infected cell nuclei: capsids that process the scaffold but do not expel it (B capsids), capsids that expel the scaffold but do not retain the viral genome (A capsids), and genome-filled C capsids (16) (17) (18) .
To visualize procapsids in living cells, we sought to fuse green fluorescent protein (GFP) with a procapsid constituent of two alpha-herpesviruses: pseudorabies virus (PRV) and herpes simplex virus 1 (HSV-1). Of several fusions engineered into PRV, only GFP fused with the protease amino terminus resulted in a viable recombinant virus. The insertion did not drastically affect HSV-1 or PRV infectivity and virulence and resulted in structural incorporation of GFP into nuclear capsids and extracellular virions. The GFP-VP24 protease fusion remained capsid associated throughout infection and was retained following arrival at the nuclear membrane. Using dual-fluorescent viruses encoding pUL25/mCherry and GFP-VP24 fusions and either a wild-type or mutant protease, procapsids in living cells were identified. Finally, the rate of pUL25/mCherry acquisition provided a measurement of capsid angularization kinetics, which was determined to be independent of DNA encapsidation.
MATERIALS AND METHODS
Cells and viruses. Vero (African green monkey kidney epithelial), and PK15 (pig kidney epithelial) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen) supplemented with 10% bovine growth supplement (BGS) (HyClone). Dorsal root ganglion (DRG) primary sensory neurons were isolated from embryonic chickens (embryonic day 8) and cultured as previously described (19) . A complete list of recombinant viruses used in this study is provided in Table 1 , and the primers used for their production by the En Passant two-step recombination procedure are listed in Table 2 . All the viruses were derived from either pBecker3 (an infectious clone of PRV strain Becker) or pYEbac102 (an infectious clone of HSV-1 strain F) (22, 23) . Viruses were produced by transfection of freshly isolated infectious clone plasmids into PK15 cells (PRV) or Vero cells (HSV-1) as previously described (24) . The resulting virus stocks were harvested and passaged on PK15 cells (PRV) or Vero cells (HSV-1) to generate working stocks, the titers of which were determined by plaque assay as described previously (25) . The UL33-null PRV encodes a deletion of codons 27 to 46, which were replaced by 4 nucleotides (TAAA) to stop translation and place the downstream codons out of frame. The deletion was designed to preserve the overlapping promoter sequences for the neighboring UL32 and UL34 essential genes. The UL33null virus was propagated on PK15 cells stably expressing PRV UL33 and did not produce detectable plaques on standard PK15 cells. HSV-1 encoding a S129P catalytic-inactivation mutation was propagated on Vero cells stably expressing HSV-1 UL26 (a kind gift from Fred Homa) and did not produce detectable plaques on standard Vero cells.
Virus propagation and plaque assays. Single-step growth curves were performed as previously described (26) . Briefly, PK15 cells were infected with PRV at a multiplicity of infection (MOI) of 10, and cell-associated virus and supernatants were harvested at 2, 5, 8, 12, and 24 h after removal of the inoculum. The titers were quantified by plaque assay on PK15 cells. Plaque diameters were measured following infection of either Vero cells (HSV-1) or PK15 cells (PRV) in 6-well trays overlaid with 3 ml DMEM supplemented with 2% BGS and 10 mg/ml methyl cellulose. The plaques were imaged 3 or 4 days postinfection either by pUL25/mCherry fluorescence or by differential interference contrast (DIC) for viruses lacking the pUL25 reporter fusion (wild-type PRV and PRV-GS5298). For each virus, a minimum of 75 plaques were imaged using a Nikon Eclipse TE2000-U inverted microscope. Plaque diameters were measured by drawing a diagonal line over the widest part of the plaque.
Infection of CD-1 mice. Male CD-1 mice (6 weeks old; Charles River) were maintained for at least 2 weeks (two or three mice per cage) under a 12-h/12-h light-dark (LD) cycle with food and water available ad libitum. Intranasal application of PRV was performed on animals anesthetized by isoflurane (2.5 to 5.0%) inhalation. Viral stocks were maintained frozen at Ϫ80°C and used immediately after being thawed. Each animal received 5 l PRV (8 ϫ 10 5 to 9 ϫ 10 5 PFU) in each nostril. Behavior was continuously video monitored, and images were captured every 10 min. The time to death after inoculation was determined from recorded images and rounded to the nearest hour. All work was approved by the University of Nebraska Institutional Animal Care and Use Committee (IACUC no. 1086).
Released-particle assay. Extracellular virus particle fluorescence was analyzed by collecting supernatants from infected cells as previously described (27) . Briefly, confluent Vero cells (for HSV-1) or PK15 cells (for PRV) in a 10-cm dish were infected at an MOI of 5 and incubated for 18 h in phenol red-free DMEM-F-12 medium (Gibco) supplemented with 2% (vol/vol) BGS (HyClone). The supernatant was collected and cleared of cell debris by centrifugation in a Legend XTR using a TX-750 swingingbucket rotor (Sorvall) at 3,000 ϫ g for 10 min at 4°C. Next, 8 ml of the cleared supernatant was transferred to an SW41 centrifuge tube and underlaid with a 1-ml cushion of 10% (wt/vol) Nycodenz (Accurate Chemical) in phosphate-buffered saline (PBS). Following centrifugation in an ultracentrifuge using an SW41 rotor (Beckman) at 38,500 ϫ g (maximum) for 60 min at 4°C, the medium and Nycodenz cushion were removed by aspiration, and the virus pellet was resuspended in 0.1 ml PBS. The virus particles were further diluted in PBS to achieve a concentration appropriate for single-particle imaging, and 65 l was spotted onto a plasma-cleaned no. 1.5 22-by 22-mm coverslip. Imaging was performed on an Eclipse TE2000 U wide-field fluorescence microscope fitted with a 60ϫ 1.4-numerical-aperture (NA) objective (Nikon) and a CascadeII:512 camera (Roper Scientific).
Intranuclear-capsid isolation and analysis. PRV capsids from infected nuclei were isolated from PK15 cells at 18 h postinfection (hpi) following infection at an MOI of 10, as previously described (28) . Follow- ing rate zonal centrifugation through a 20 to 50% sucrose gradient, three capsid species (A, B, and C) were identified as light-scattering bands and collected using a gradient fractionator (BioComp Instruments). For fluorescence microscopy experiments, the isolated capsids were spotted on glass coverslips and imaged as described for the released-particle assay. For mass spectrometry analysis, total protein from the B band was precipitated by the addition of trichloroacetic acid (TCA) to a 10% final concentration. Following a 1-h incubation on ice, samples were centrifuged in a Microfuge 18 (Beckman Coulter) at maximum speed (18,000 ϫ g) for 10 min in a 4°C refrigerator. The supernatant was aspirated, and the pellet was resuspended in protein-loading buffer (31.25 mM Tris [pH 6.8], 5% glycerol, 1% SDS, 0.005% bromophenol blue, 5% ␤-mercaptoethanol) supplemented with 0.1 N NaOH. Samples were then separated by SDS-PAGE, stained with Coomassie blue (Bio-Rad), destained with water, and imaged with a flat-bed scanner. The bands corresponding to VP24 (wildtype [WT] PRV) or GFP-VP24 (PRV-GS5298) were excised from the gel and submitted for mass spectrometry at the Northwestern Proteomics Core.
Mass spectrometry sample preparation. Gel slices containing protein bands were excised from an SDS-PAGE gel, diced into small pieces, destained in 500 l of 100 mM ammonium bicarbonate (AmBic) for 1 h with shaking, and dehydrated by shaking for 10 min in 50% acetonitrile (ACN)-50% 100 mM AmBic, followed by 10 min of shaking in 100% ACN. The supernatant was then replaced with 100 l of 10 mM dithiothreitol-100 mM AmBic. Samples were shaken at 50°C for 30 min to reduce cysteines, and the cysteine residues were subsequently alkylated with 100 l of 100 mM iodoacetamide by incubating for 30 min in the dark at room temperature. The gel pieces were then washed in 500 l of 50% ACN-50% 100 mM AmBic with shaking at 50°C for 45 min. Next, the gel pieces were incubated for 15 min in 100% ACN prior to drying in a vacuum concentrator and subsequently rehydrated in 100 l of 50-ng/l sequencing-grade trypsin (Promega, Madison, WI) in 100 mM AmBic. Samples were kept at 37°C overnight. Peptides were extracted from the gel with sequential additions of 5% ACN-0.1% formic acid (FA), 30% ACN-5% FA, and 90% ACN-5% FA. The pooled extracts were dried in a vacuum concentrator and directly resuspended in 30 l of 5% ACN-0.1% FA for liquid chromatography-mass spectrometry (LC-MS) analysis.
LC-MS analysis. Peptides were analyzed by LC-tandem MS (MS-MS) using an Easy nanoLC-II system (Thermo Fisher Scientific) and a linear trap quadropole (LTQ) Orbitrap Velos (Thermo Fisher Scientific) hybrid mass spectrometer. Ten-microliter injections of peptide samples were loaded onto the trap column, which was 150 m by 3 cm self-packed with 3-m C 18 beads. The analytical column was a 75-m by 10.5-cm Pico-Chip column packed with 1.9-m C 18 beads. The flow rate was kept at 300 nl/min. Solvent A was 0.1% FA in water, and solvent B was 0.1% FA in ACN. The gradient began at 5% B, was ramped to 35% B in 45 min and increased to 45% B over 10 min, and then was washed out at 100% B and reequilibrated to 5% B. The mass spectrometer was operated in datadependent mode. The source voltage was 1.90 kV, and the capillary temperature was 275°C. Intact peptide mass scans (MS 1 ) were acquired from 400 to 2,000 m/z at 60,000 resolving power, and automatic gain control (AGC) was set to 1 ϫ 10 6 . The top 10 most abundant precursor ions in each MS 1 scan were selected for fragmentation. Precursors were selected with an isolation width of 1.5 Da and fragmented by collision-induced dissociation at 35% normalized collision energy, with activation Q equal to 0.250. Previously selected ions were dynamically excluded from reselection for 60 s. The fragmentation scan (MS 2 ) AGC was set to 3 ϫ 10 4 . Proteins were identified from the MS raw files using Proteome Discoverer software. MS-MS spectra were searched against the Swiss-Prot pig database, using the Sequest database search algorithm. Carbamidomethyl cysteine and oxidized methionine were set as variable modifications, and two missed tryptic cleavages were allowed. The MS 1 precursor mass tolerance was set to 10 ppm, and the MS 2 tolerance was set to 0.6 Da. A 1% falsediscovery rate cutoff was applied at the peptide level. Only proteins with a TABLE 2 Primers used to construct PRV strain Becker and HSV-1 strain F recombinants unique to the study
The underlined sequences are homologous to the plasmid template. minimum of two unique peptides above the cutoff were considered for further study. Live-cell fluorescence microscopy. To monitor GFP-VP24 and pUL25/mCherry capsid signals during infection, cells were imaged in wax-sealed chambers as previously described (19) . Imaging of incoming capsids at nuclear rims was achieved 2.5 to 3.0 hpi in explanted DRGs exposed to 1 ϫ 10 7 PFU per coverslip. Intranuclear-capsid assemblies were imaged following infection of Vero cells under varying conditions, as noted in the figure legends. A Ti inverted microscope fitted with 60ϫ 1.4-NA and 100ϫ 1.45-NA objectives (Nikon Instruments) and coupled with a CSU-W1 confocal head (Yokogawa Electric Corporation) and a CascadeII:1024 EM-CCD (Photometrics) was housed in a environmental box set to 37°C (InVivo Scientific). Illumination was provided by Obis 488 and Sapphire 561 lasers (Coherent) and custom laser launch (Solamere Technology Group, Inc.).
RESULTS

Fusion of the green fluorescent protein with the maturation protease.
To visualize procapsids in living cells, we produced a series of GFP fusions with the procapsid scaffold and the maturation protease of PRV. Similar to those of HSV-1, the PRV scaffold proteins (pUL26 and pUL26.5) are encoded by two overlapping genes, UL26 and UL26.5, so that the UL26.5 open reading frame (ORF) is in frame with and corresponds to the 3= portion of UL26 (29, 30) . The VP24 maturation protease is housed in the amino terminus of pUL26 and upon activation autocatalytically releases from the scaffold backbone by cleavage at its release (R) site (30) (31) (32) . VP24 also severs both scaffold proteins from the interior surface of the capsid shell by cleavage at the maturation (M) site (31) . The resulting VP21 and VP22a products are expelled from the capsid, while VP24 and, presumably, a 25-amino-acid C-terminal scaffold fragment remain as structural components (11) (12) (13) (14) (15) (33) (34) (35) . Based on these findings, four fusions were designed to position GFP at the N terminus of the protease, at the N terminus of pUL26.5, near the C terminus of VP21/VP22a, and in the pUL26/ pUL26.5 C-terminal fragment ( Fig. 1 and Table 1 ).
The GFP coding sequence was introduced into an infectious clone of PRV strain Becker, and the resulting constructs were transfected into pig kidney epithelial (PK15) cells to produce virus stocks (23) . Of the four recombinant viruses, only PRV encoding GFP fused to the amino terminus of the VP24 protease (GFP-VP24) proved viable. A dual-fluorescent variant of the GFP-VP24 virus that also encodes a pUL25/mCherry fusion, which tags capsids with red fluorescence following scaffold proteolytic processing, was produced to assist with analysis of capsid maturation (see below) (27, 36) . Fusion of GFP to the amino terminus of VP24 did not substantially impair the single-step growth kinetics of PRV ( Fig. 2A) , although a small reduction in virulence was noted based on the mean survival time following intranasal installation of CD-1 mice that was on par with that of a traditional GFP-VP26 capsid reporter virus (Fig. 2B) (19) . Based on these encouraging results, an HSV-1 strain F recombinant encoding the equivalent pUL25/mCherry and GFP-VP24 fusions was produced. The plaque diameters of the HSV-1 and PRV recombinants were within 15% of those of the parental strains (Fig. 2C) , and the final titers approximated those of the respective parental strains ( Table  1) . Taken together, these data indicated that inserting GFP at the amino terminus of the VP24 maturation protease was tolerated by the viruses.
GFP-VP24 incorporation into capsids and virions. The VP24 maturation protease is a component of all capsid species, either as a fusion to the scaffold (procapsids) (5, 9, 37) , as a liberated peptide within A, B, and C (A/B/C) capsids isolated from infected cell nuclei (11, 13, 33, 37) , or in capsids isolated from extracellular virus particles. The copy number of VP24 in B capsids is estimated at 147 (38) , which can be extrapolated to all capsid species, as the protease content does not substantially vary between them (16, 33, 39) . To determine the copy number of the GFP-VP24 fusion, nuclear A, B, and C capsids were separated on 20 to 50% sucrose gradients following their isolation from PK15 cells infected with PRV encoding either unmodified or GFP-tagged VP24 (28) . The integrity of the GFP-VP24 polypeptide incorporated into capsids was confirmed by Western blotting with an anti-GFP antibody (data not shown). The protein composition of the B capsids was first analyzed by SDS-PAGE, followed by Coomassie blue staining. Wild-type VP24 was detected as a 27-kDa species (39) , which was replaced by an ϳ50-kDa band in B capsids isolated from the GFP-VP24 virus (Fig. 3A) . The identities of the VP24 and GFP-VP24 bands were confirmed by mass spectrometry (see Tables S1 and S2 in the supplemental material). Next, GFP emissions from individual capsids were measured by spotting the capsids on glass coverslips and imaging by quantitative fluorescence microscopy. The distribution of diffraction-limited fluorescence intensities was Gaussian for the three capsid types, consistent with copy-controlled incorporation of GFP-VP24 ( Fig. 3B) (21) . To determine the copy number of GFP-VP24 per capsid, a GFP emission profile from a pUL25/GFP-encoding PRV recombinant was used as a standard (PRV-GS3171) ( Table 1) . We had previously determined that pUL25/GFP fusions are copy controlled at approximately 70.5 copies per capsid (21) . In comparison, GFP-VP24 was present at approximately 25 copies per capsid for the three capsid types (Fig. 3C ). This level of incorporation was 6-fold lower than expected (38) , which was consistent with reduced incorporation of the GFP fusion observed on denaturing gels (Fig. 3A) . The cause of this reduction is not immediately clear but may have resulted from steric hindrance within the crowded scaffold environment combined with the flexibility of the scaffold to use reduced amounts of pUL26 during assembly (40) .
Extracellular dual-fluorescent HSV-1 and PRV particles were isolated from the supernatants of infected cells at 18 hpi and spotted on coverslips for analysis, as described above. The particles displayed coincident GFP-VP24 and pUL25/mCherry signals, as was expected for these two copy-controlled structural proteins (Fig. 4A ). As with capsids isolated from nuclei, the GFP emissions from the extracellular particles had a Gauss-ian distribution, with the specific GFP-VP24 incorporation into PRV and HSV-1 virions equivalent to the copy numbers calculated for nuclear capsids (Fig. 4B and C) . These results also indicated that the pUL25/mCherry fusion did not alter GFP-VP24 occupation. 
GFP-VP24 is retained in capsids following entry into cells.
Although the VP24 protease is a component of extracellular viral particles, whether the protease is retained following entry into cells and during capsid delivery to nuclear pores is unknown. To examine the GFP-VP24 content of intracellular capsids, the nuclei of primary sensory neurons were imaged following infection with dual-fluorescent HSV-1 or PRV encoding GFP-VP24 and pUL25/ mCherry. Capsids at the nuclear rim were consistently positive for both fluorescent signals, indicating that GFP-VP24 remains capsid associated following entry into cells and was evidently not injected into nuclei (Fig. 5 ). Diffuse intranuclear fluorescence was also observed to various degrees, likely resulting from de novo protein synthesis.
Identifying procapsids in living cells. The addition of the pUL25 and VP26 proteins to the capsid surface occurs upon scaffold cleavage and concurrent angularization of the capsid shell (4-7). Therefore, pUL25 and VP26 are markers of A/B/C capsids that are restricted from procapsids. Both of these proteins are traditionally used to label capsids with fluorescent protein fusions, with pUL25 being particularly tolerant of such reporters (27, 36, 41) . In contrast, the GFP-VP24 fusion was expected to label all capsid species, including procapsids. As a first step to determining if procapsids were labeled, a VP24 S129P codon change was introduced into the dual-fluorescent HSV-1 to disrupt the active-site nucleophile and thereby catalytically inactivate the protease (42, 43) . Inactivation of the protease renders HSV-1 unable to trigger procapsid maturation, and consistent with this, the S129P virus could be propagated only on a trans-complementing cell line that expressed wild-type pUL26 (Table 1) (42, 44) . Following infection of noncomplementing cells, GFP-VP24 diffraction-limited punctae were readily observed within infected cell nuclei, and these structures uniformly lacked red fluorescence (Fig. 6 ). Occasional dual-fluorescent punctae detected at the nuclear periphery that were consistent with the input capsids that initiated the infection were observed. The GFP-VP24 particles displayed random motion in the nucleus similar to that described for angularized capsids labeled with GFP-VP26 fusions (see Movie S1 in the supplemental material) (45) .
Because GFP-VP24 assembled into diffraction-limited structures in the absence of a catalytically active maturation protease, we next examined whether these structures were discernible during infection with virus encoding wild-type protease and if the particles acquired the pUL25/mCherry maturation marker. At 6 h postinfection, punctate GFP-VP24 emission profiles were again detected in the absence of pUL25/mCherry signal. As the infection progressed over the next 2 h, many of the GFP-VP24 emission sources became coincident with pUL25/mCherry signal (Fig. 7) . This protease-dependent acquisition of the pUL25/mCherry capsid shell maturation marker was consistent with the GFP-VP24 emission sources being procapsids. For both HSV-1 and PRV, the sites of capsid maturation were distributed throughout the nucleus. Taken together, these observations indicate that GFP-VP24 is a pancapsid marker that allows visualization of procapsids and their morphogenesis.
The herpesvirus terminase does not enhance capsid angularization. An unexpected aspect of herpesvirus capsid maturation is the apparently low efficiency of the process. Many capsids isolated from the nuclei of cells infected with HSV-1 and PRV have a cleaved scaffold and lack encapsidated viral genomes (i.e., B capsids) (16, 28, 46) . This inefficiency can be accounted for, at least in part, by the finding that terminase mutant viruses produce abundant B capsids, which indicates that VP24 can activate in the absence of genome encapsidation (47) (48) (49) (50) (51) . Whether genome-containing C capsids are the products of chance events that saw terminase and protease activities triggered concurrently or whether terminase can enhance protease activation to help promote a coupled scaffold-genome exchange is unknown. Using the dual-fluorescent PRV, the ki- netics of pUL25/mCherry acquisition and its dependence upon encapsidation were assessed in the presence (WT UL33) and absence (⌬UL33) of a functional terminase complex (28, 48, 51) . UL33 encodes an essential component of the viral termi-nase that packages the viral genome into capsids; as such, PRV with UL33 deleted could be propagated only on a trans-complementing cell line (Table 1) . Infections with WT UL33 and ⌬UL33 dual-fluorescent PRV were monitored every 5 min be- ginning at 5 h postinfection. For each infection, the time between the first appearance of GFP-VP24 intranuclear punctae and the onset of pUL25/mCherry acquisition was determined. GFP-VP24 punctae generally persisted for 35 min prior to acquisition of the pUL25/mCherry maturation marker, and this period was not detectably impacted by the absence of a functional terminase (Fig. 8 ).
DISCUSSION
Herpesvirus capsid assembly and maturation have long been considered targets for antiviral development, and significant efforts have been applied to understand this fundamental aspect of infec-tion. Several approaches have provided important insights into these processes, including analysis of temperature-sensitive assembly defects (4, 6, 9, 10, 40, 47) , reconstitution of capsid assembly by baculovirus expression (37, (52) (53) (54) , and three-dimensional reconstruction of capsid intermediates by cryo-electron microscopy (5, 8, 17, (55) (56) (57) (58) (59) (60) (61) . Collectively, these studies have helped define the procapsid precursor and its three maturation products: A, B, and C capsids. By transmission electron microscopy, the procapsid appears as a 125-nm shell containing a large concentric core, which collapses to a small core following scaffold cleavage (16, 18, 62) . Thus, HSV-1 encoding temperature-sensitive mutations in the maturation protease produces only large-core capsids at nonpermissive temperatures (9, 10, 47) . Production of C capsids consists of at least two maturation events that are closely coupled: capsid shell angularization and genome encapsidation (17, 18, 63) . Little is known regarding the circumstances that govern these events, and this has in part been due to an inability to monitor procapsids in living cells. Whereas imaging of fluorescent reporter viruses has been instrumental in studying many aspects of the herpesvirus infectious cycle, studying the dynamics of capsid assembly and morphogenesis has been constrained by the lack of a suitable reporter design that provides for procapsid imaging.
Two approaches have proven effective in imaging capsids in living cells. Tagging either the VP26 hexon tip protein (64) or the pUL25 outer penton protein (36, 41) with a fluorescent protein results in fluorescent capsids that allow imaging and tracking of individual particles in cells. The high copy number of VP26 provides bright fluorescent emissions when fused with a fluorescent protein but can impair aspects of herpesvirus infection (65, 66) , whereas fusion with pUL25 yields 4-fold-dimmer fluorescence emissions than an equivalent VP26 reporter and is less detrimental to the virus (27) . However, neither of these proteins is useful for labeling of procapsids, as both are added to the outer capsid shell upon its angularization, which is triggered by internal scaffold cleavage (4-7). Therefore, VP26 and pUL25 are markers of capsids that have a mature shell, which include A, B, and C capsids isolated from infected cell nuclei and C capsids isolated from extracellular virions (6, 7, 12, 14, 38, 67) . To image the procapsid progenitor, we made recombinants of PRV that encode GFP fused to different regions of the pUL26/pUL26.5 scaffold proteins. While the majority of these designs were lethal to PRV, we report the construction and analysis of recombinant PRV and HSV-1 with GFP fused to the VP24 maturation protease that maintained nearly wild-type infectivity.
Fusing GFP to VP24 achieves two useful advances. First, unlike fusions to VP26 and pUL25, which decorate the capsid surface with GFP, the fluorescent protein is contained within the capsid shell. By leaving the outer capsid surface free of GFP decoration, capsid interactions with many cellular and viral factors should remain unperturbed. Second, the GFP-VP24 fusion makes the procapsid accessible to studies of its dynamics and maturation in living cells. To confirm that the GFP-VP24 reporter fusion provided a reliable procapsid signal, a virus encoding GFP-VP24 and pUL25/mCherry was produced, with the expectation that procapsids would emit green, but not red, fluorescence. This virus was further altered to encode a catalytically inactive protease (S129P mutation in VP24) to prevent procapsid maturation (42, 44) . Consistent with expectations, green-fluorescent diffraction-limited intranuclear punctae became prevalent in the nuclei of infected cells, and these structures failed to acquire red fluorescence. These particles exhibited random motion, similar to a report of angularized capsids (45) . In contrast, the pUL25/mCherry signal was acquired by green-fluorescent particles in the presence of a wild-type protease. These observations authenticate the GFP-VP24 fusion as a procapsid reporter and demonstrate the utility of the fusion in visualizing procapsids in living cells. It should be emphasized, however, that GFP-VP24 is not specific to procapsids but rather labels all capsid species.
The copy number of the VP24 protease in B capsids was previously estimated at 147 copies by densitometric analysis of Coomassie blue-stained SDS-PAGE gels (38) . Because procapsids are unstable when isolated from nuclei (5), fluorescent emissions were measured from purified A/B/C capsids and virions to determine the GFP-VP24 copy number, which approximated 25 copies/capsid. We note that this value is 6-fold lower than expected, which was supported by our Coomassie blue analysis of B capsid composition. Therefore, we conclude that the copy number of GFP in the capsid interior is likely limited by the crowded environment. This is a noteworthy constraint, considering the use of this fusion in studies of scaffold assembly. Despite the decreased copy number of pUL26, the GFP-VP24 reporter was tolerated by HSV-1 and PRV remarkably well. Tagging VP24 with GFP did not impair single-step growth of PRV, and decreases in plaque diameter and virulence in a mouse model were statistically significant but not severe.
Using the dual-fluorescent recombinants of PRV encoding GFP-VP24 and pUL25/mCherry, procapsids were consistently detected in infected cell nuclei approximately 35 min before association with the pUL25/mCherry marker became evident. This maturation time was consistent with a previous estimate based on HSV-1 encoding a temperature-sensitive protease and the detection of capsid angularization using a conformation-specific antibody (10) . There was no obvious preferential site for procapsid assembly or maturation, as both processes appeared to occur randomly throughout the interior of the nucleus. Although genome encapsidation is not a prerequisite for capsid angularization, we were curious if the former promotes the latter, as such a scenario would help favor the production of C capsids. Within the resolution limits of the assay, this proved not to be the case; procapsids of a terminase mutant virus (UL33 null) acquired the pUL25/ mCherry maturation marker at the same rate as wild-type virus. These results indicate that the rates of protease activation, scaffold cleavage, and capsid angularization were not measurably reduced in the absence of a functional terminase. The finding is consistent with the high yield of B capsids normally obtained from cells infected with wild-type HSV-1 and PRV and suggests that successful encapsidation may require fortuitous timing of encapsidation and scaffold cleavage. Alternatively, during wild-type infections, some encapsidation events may be coupled with nuclear egress, with the resulting C capsids being rapidly lost from the intranuclear-capsid population.
In summary, this study describes recombinant PRV and HSV-1 expressing a fluorescent-protein fusion with a core protein present in procapsids, as well as all other capsid species, which is therefore the first herpesvirus pancapsid live-cell marker. The approach makes investigation of capsid assembly, maturation, encapsidation, nuclear egress, and the coordination of these processes accessible in living cells. Our initial application of this technology reveals procapsids to be dynamic particles that exhibit random intranuclear motion and maturation kinetics that are independent of genome encapsidation.
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